- Table of Contents:
-
- CHAPTER ONE: EXECUTIVE SUMMARY
-
Scope and Methodology
-
Overview
-
Emerging Vaccines and Forecasts
-
The Global Market for Emerging Vaccines
- CHAPTER TWO: INTRODUCTION TO VACCINES
-
A Brief History: The Development of Vaccines
-
The Immune Response
-
Mechanism of Action
-
Types of Vaccines
-
Attenuated (Weakened) Live Viruses
-
Killed (Inactivated) Viruses
-
Toxoid Vaccines
-
Genetically Engineered/Modified Vaccines
-
Bacteria-Based Vaccines
-
Subunit Vaccines
-
Conjugate Vaccines
-
DNA Vaccination
-
Vaccine Approval Process
-
Trends Driving the Vaccines Market
- CHAPTER THREE: EMERGING VACCINES
-
Introduction
-
Emerging Vaccines by Disease Area
-
Addiction
-
Smoking
-
Allergy
-
Alzheimer’s Disease
-
Anthrax
-
Asthma
-
Campylobacter Infection
-
Chlamydia
-
Croup
-
Dengue Fever
-
Diabetes
-
Ebola
-
Epstein-Barr Virus
-
Enterotoxigenic Escherichia coli
-
Heart Attack
-
Helicobacter Pylori
-
Hepatitis
-
Hepatitis C
-
Hepatitis E
-
Herpesvirus
-
Hookworm
-
Hypertension
-
HIV/AIDS
-
Leishmaniasis
-
Malaria
-
MRSA Infection
-
Multiple Sclerosis
-
Obesity
-
Parainfluenza Virus Type 3
-
Parkinson’s Disease
-
Plague
-
Respiratory Syncytial Virus
-
Ross River Virus
-
Shigellosis
-
Stroke
-
Tuberculosis
-
West Nile Virus
- CHAPTER FOUR: EMERGING VACCINES MARKET FORECAST
-
Global Market for Emerging Vaccines
-
Emerging Vaccines Market Segment Forecasts
-
Addiction
-
Allergies
-
Alzheimer’s Disease
-
Anthrax
-
Asthma
-
Campylobacter Infection
-
Chlamydia
-
Croup
-
Dengue Fever
-
Diabetes
-
Ebola
-
EBV Infection
-
ETEC Infection
-
Heart Attack
-
H. Pylori Infection
-
Hepatitis C and E
-
Herpesvirus Infection
-
Hookworm
-
Hypertension
-
HIV/AIDS
-
Leishmaniasis
-
Malaria
-
MRSA Infection
-
Multiple Sclerosis
-
Obesity
-
PIV-3 Infection
-
Parkinson’s Disease
-
Plague
-
RSV Infection
-
Ross River Virus Infection
-
Shigellosis
-
Stroke
-
Tuberculosis
-
West Nile Virus
- CHAPTER FIVE: ISSUES AND TRENDS
-
New Vaccine Technologies
-
DNA Vaccination
-
Innovative Delivery Systems
-
Edible Vaccines
-
Mucosal Delivery
-
Intranasal Delivery
-
Vaccine Patches
-
Funding Shortfalls
- CHAPTER SIX: COMPANY PROFILES
-
Acambis plc
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
ACE BioSciences
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
AFFiRiS
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
ALK-Abello A/S
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Allergy Therapeutics
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Bavarian Nordic A/S
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Baxter Healthcare
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Celldex Therapeutics
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Crucell
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Cytos Biotechnology
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial
-
GlaxoSmithKline
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Hawaii Biotech
-
History and Lines of Business
-
Emerging Vaccine Products
-
Financial Information
-
Intercell
-
History and Lines of Business
-
Emerging Vaccine Products
-
Financial Information
-
Medimmune
-
History and Lines of Business
-
Emerging Vaccine Products
-
Financial Information
-
Merck & Co. Inc
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Mymetics
-
History and Lines of Business
-
Emerging Vaccine Products
-
Financial Information
-
Nabi Biopharmaceuticals
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Novartis
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Opexa Therapeutics
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Paladin Labs
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
-
Sanofi Pasteur
-
History and Lines of Business
-
Emerging Vaccine Activities
-
Financial Information
- Appendix
- Company Directory
- LIST OF EXHIBITS
- CHAPTER ONE: EXECUTIVE SUMMARY
-
Table 1-1: Status of Emerging Vaccines by Disease
- CHAPTER TWO: INTRODUCTION TO VACCINES
-
Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2008
-
Table 2-2: Vaccine-Preventable Diseases, December 2009
-
Table 2-3: VAERS Table of Reportable Events Following Vaccination
- CHAPTER THREE: EMERGING VACCINES
-
Figure 3-1: Global Prevalence of Conditions Addressed by Emerging Vaccines
-
Figure 3-2: Comparative Mortality, Symptom Severity and Treatment Availability for Conditions Addressed by Emerging Vaccines
-
Table 3-1: Emerging Vaccines by Disease and Stage of Testing
-
Figure 3-3: Comparative Severity Ranking of Addiction
-
Figure 3-4: Comparative Severity Ranking of Allergy
-
Figure 3-5: Comparative Severity Ranking of Alzheimer’s Disease
-
Figure 3-6: Comparative Severity Ranking of Anthrax
-
Figure 3-7: Comparative Severity Ranking of Asthma
-
Figure 3-8: Comparative Severity Ranking of Campylobacter Infection
-
Figure 3-9: Comparative Severity Ranking of Chlamydia
-
Figure 3-10: Comparative Severity Ranking of Croup
-
Figure 3-10: Comparative Severity Ranking of Dengue Fever
-
Figure 3-12: Comparative Severity Ranking of Diabetes
-
Figure 3-13: Comparative Severity Ranking of Ebola
-
Figure 3-14: Comparative Severity Ranking of EBV
-
Figure 3-15: Comparative Severity Ranking of ETEC
-
Figure 3-16: Comparative Severity Ranking of Heart Attack
-
Figure 3-17: Comparative Severity Ranking of H. Pylori Infection
-
Figure 3-10: Comparative Severity Ranking of Hepatitis C and E
-
Figure 3-19: Comparative Severity Ranking of Herpesvirus Infection
-
Figure 3-20: Comparative Severity Ranking of Hookworm
-
Figure 3-21: Comparative Severity Ranking of Hypertension
-
Figure 3-10: Comparative Severity Ranking of HIV/AIDS
-
Figure 3-23: Comparative Severity Ranking of Leishmaniasis
-
Figure 3-24: Comparative Severity Ranking of Malaria
-
Figure 3-25: Comparative Severity Ranking of MRSA Infection
-
Figure 3-26: Comparative Severity Ranking of Multiple Sclerosis
-
Figure 3-27: Comparative Severity Ranking of Obesity
-
Figure 3-28: Comparative Severity Ranking of PIV-3 Infection
-
Figure 3-29: Comparative Severity Ranking of Parkinson’s Disease
-
Figure 3-30: Comparative Severity Ranking of Plague
-
Figure 3-31: Comparative Severity Ranking of RSV Infection
-
Figure 3-32: Comparative Severity Ranking of Ross River Virus Infection
-
Figure 3-33: Comparative Severity Ranking of Shigellosis
-
Figure 3-34: Comparative Severity Ranking of Stroke
-
Figure 3-35: Comparative Severity Ranking of Tuberculosis
-
Figure 3-36: Comparative Severity Ranking of West Nile Virus Infection
- CHAPTER FOUR: EMERGING VACCINES MARKET FORECAST
-
Table 4-1: World Market for Emerging Vaccines by Type, 2009-2020
-
Table 4-2: World Market for Emerging Vaccines by Type, 2009-2020
-
Table 4-3: World Addiction Vaccine Market 2009-2020
-
Table 4-4: World Allergy Vaccine Market 2009-2020
-
Table 4-5: World Alzheimer’s Disease Vaccine Market 2009-2020
-
Table 4-6: World Anthrax Vaccine Market 2009-2020
-
Table 4-7: World Asthma Vaccine Market 2009-2020
-
Table 4-8: World Campylobacter Infection Vaccine Market 2009-2020
-
Table 4-9: World Chlamydia Vaccine Market 2009-2020
-
Table 4-10: World Croup Vaccine Market 2009-2020
-
Table 4-11: World Dengue Fever Vaccine Market 2009-2020
-
Table 4-12: World Diabetes Vaccine Market 2009-2020
-
Table 4-13: World Ebola Vaccine Market 2009-2020
-
Table 4-14: World EBVVaccine Market 2009-2020
-
Table 4-15: World ETECVaccine Market 2009-2020
-
Table 4-16: World Heart Attack Vaccine Market 2009-2020
-
Table 4-17: World H. Pylori Vaccine Market 2009-2020
-
Table 4-18: World Hepatitis C and E Vaccine Market 2009-2020
-
Table 4-19: World Herpesvirus Vaccine Market 2009-2020
-
Table 4-20: World Hookworm Vaccine Market 2009-2020
-
Table 4-21: World Hypertension Vaccine Market 2009-2020
-
Table 4-22: World HIV/AIDS Vaccine Market 2009-2020
-
Table 4-23: World Leishmaniasis Vaccine Market 2009-2020
-
Table 4-24: World Malaria Vaccine Market 2009-2020
-
Table 4-25: World MRSA Vaccine Market 2009-2020
-
Table 4-26: World Multiple Sclerosis Vaccine Market 2009-2020
-
Table 4-27: World Obesity Vaccine Market 2009-2020
-
Table 4-28: World PIV-3 Vaccine Market 2009-2020
-
Table 4-29: World Parkinson’s Disease Vaccine Market 2009-2020
-
Table 4-30: World Plague Vaccine Market 2009-2020
-
Table 4-31: World RSV Vaccine Market 2009-2020
-
Table 4-32: World Ross River Virus Vaccine Market 2009-2020
-
Table 4-33: World Shigellosis Vaccine Market 2009-2020
-
Table 4-34: World Stroke Vaccine Market 2009-2020
-
Table 4-35: World Tuberculosis Vaccine Market 2009-2020
-
Table 4-36: World West Nile Virus Vaccine Market 2009-2020
